Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,424.05
(
0.31%
)
US TECH 100
28,469.60
(
0.64%
)
Dow Jones
49,552.78
(
-0.42%
)
Brent Oil
104.35
(
-1.33%
)
Bitcoin
78,918.63
(
-1.95%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: InternetForumUser post# 247654

Wednesday, 01/06/2016 6:43:11 AM

Wednesday, January 06, 2016 6:43:11 AM

Post# of 347009
Jeanette Bleecker and others were removed (from other places) as well. I guess all good things (for some) were forced to come to an end.

I still see the King standing at Peregrine and maybe lots of options may be in store for a soon to be recognized job well done.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote